312 related articles for article (PubMed ID: 19053167)
21. Tumor associated antigen specific T-cell populations identified in ex vivo expanded TIL cultures.
Junker N; Kvistborg P; Køllgaard T; Straten Pt; Andersen MH; Svane IM
Cell Immunol; 2012; 273(1):1-9. PubMed ID: 22230732
[TBL] [Abstract][Full Text] [Related]
22. Head and neck squamous cell carcinoma cell line-induced suppression of in vitro lymphocyte proliferative responses.
Lapointe H; Lampe H; Banerjee D
Otolaryngol Head Neck Surg; 1992 Feb; 106(2):149-58. PubMed ID: 1738546
[TBL] [Abstract][Full Text] [Related]
23. Presence of the T-cell activation marker OX-40 on tumor infiltrating lymphocytes and draining lymph node cells from patients with melanoma and head and neck cancers.
Vetto JT; Lum S; Morris A; Sicotte M; Davis J; Lemon M; Weinberg A
Am J Surg; 1997 Sep; 174(3):258-65. PubMed ID: 9324133
[TBL] [Abstract][Full Text] [Related]
24. Immunomodulatory role of bitter melon extract in inhibition of head and neck squamous cell carcinoma growth.
Bhattacharya S; Muhammad N; Steele R; Peng G; Ray RB
Oncotarget; 2016 May; 7(22):33202-9. PubMed ID: 27120805
[TBL] [Abstract][Full Text] [Related]
25. Method for estimation of apoptotic cell fraction of cytotherapy using in vivo fluorine-19 magnetic resonance: pilot study in a patient with head and neck carcinoma receiving tumor-infiltrating lymphocytes labeled with perfluorocarbon nanoemulsion.
Ahrens ET; Helfer BM; O'Hanlon CF; Lister DR; Bykowski JL; Messer K; Leach BI; Chen J; Xu H; Daniels GA; Cohen EEW
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37339797
[TBL] [Abstract][Full Text] [Related]
26. PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer.
Badoual C; Hans S; Merillon N; Van Ryswick C; Ravel P; Benhamouda N; Levionnois E; Nizard M; Si-Mohamed A; Besnier N; Gey A; Rotem-Yehudar R; Pere H; Tran T; Guerin CL; Chauvat A; Dransart E; Alanio C; Albert S; Barry B; Sandoval F; Quintin-Colonna F; Bruneval P; Fridman WH; Lemoine FM; Oudard S; Johannes L; Olive D; Brasnu D; Tartour E
Cancer Res; 2013 Jan; 73(1):128-38. PubMed ID: 23135914
[TBL] [Abstract][Full Text] [Related]
27. Prognostic impact of immune microenvironment in laryngeal and pharyngeal squamous cell carcinoma: Immune cell subtypes, immuno-suppressive pathways and clinicopathologic characteristics.
Karpathiou G; Casteillo F; Giroult JB; Forest F; Fournel P; Monaya A; Froudarakis M; Dumollard JM; Prades JM; Peoc'h M
Oncotarget; 2017 Mar; 8(12):19310-19322. PubMed ID: 28038471
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.
Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z
BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420
[TBL] [Abstract][Full Text] [Related]
29. Tumor-infiltrating lymphocytes in oral cavity squamous cell carcinoma and its association with clinicopathological parameters.
Ahuja S; Khan AA; Zaheer S; Ranga S
Pathol Res Pract; 2023 Nov; 251():154882. PubMed ID: 37898039
[TBL] [Abstract][Full Text] [Related]
30. PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1hiCD39+ CD4 T cells.
Balança CC; Salvioni A; Scarlata CM; Michelas M; Martinez-Gomez C; Gomez-Roca C; Sarradin V; Tosolini M; Valle C; Pont F; Ferron G; Gladieff L; Vergez S; Dupret-Bories A; Mery E; Rochaix P; Fournié JJ; Delord JP; Devaud C; Martinez A; Ayyoub M
JCI Insight; 2021 Jan; 6(2):. PubMed ID: 33332284
[TBL] [Abstract][Full Text] [Related]
31. Blockade of MCP-1/CCR4 signaling-induced recruitment of activated regulatory cells evokes an antitumor immune response in head and neck squamous cell carcinoma.
Sun W; Li WJ; Wei FQ; Wong TS; Lei WB; Zhu XL; Li J; Wen WP
Oncotarget; 2016 Jun; 7(25):37714-37727. PubMed ID: 27177223
[TBL] [Abstract][Full Text] [Related]
32. PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients.
Kim HR; Ha SJ; Hong MH; Heo SJ; Koh YW; Choi EC; Kim EK; Pyo KH; Jung I; Seo D; Choi J; Cho BC; Yoon SO
Sci Rep; 2016 Nov; 6():36956. PubMed ID: 27841362
[TBL] [Abstract][Full Text] [Related]
33. T regulatory type 1 cells in squamous cell carcinoma of the head and neck: mechanisms of suppression and expansion in advanced disease.
Bergmann C; Strauss L; Wang Y; Szczepanski MJ; Lang S; Johnson JT; Whiteside TL
Clin Cancer Res; 2008 Jun; 14(12):3706-15. PubMed ID: 18559587
[TBL] [Abstract][Full Text] [Related]
34. Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma.
Oble DA; Loewe R; Yu P; Mihm MC
Cancer Immun; 2009 Apr; 9():3. PubMed ID: 19338264
[TBL] [Abstract][Full Text] [Related]
35. CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG).
Balermpas P; Rödel F; Rödel C; Krause M; Linge A; Lohaus F; Baumann M; Tinhofer I; Budach V; Gkika E; Stuschke M; Avlar M; Grosu AL; Abdollahi A; Debus J; Bayer C; Stangl S; Belka C; Pigorsch S; Multhoff G; Combs SE; Mönnich D; Zips D; Fokas E
Int J Cancer; 2016 Jan; 138(1):171-81. PubMed ID: 26178914
[TBL] [Abstract][Full Text] [Related]
36. Increased PD-1
Jie HB; Srivastava RM; Argiris A; Bauman JE; Kane LP; Ferris RL
Cancer Immunol Res; 2017 May; 5(5):408-416. PubMed ID: 28408386
[TBL] [Abstract][Full Text] [Related]
37. Immune suppression in head and neck cancers: a review.
Duray A; Demoulin S; Hubert P; Delvenne P; Saussez S
Clin Dev Immunol; 2010; 2010():701657. PubMed ID: 21437225
[TBL] [Abstract][Full Text] [Related]
38. Proportion of CD4 and CD8 tumor infiltrating lymphocytes predicts survival in persistent/recurrent laryngeal squamous cell carcinoma.
Hoesli R; Birkeland AC; Rosko AJ; Issa M; Chow KL; Michmerhuizen NL; Mann JE; Chinn SB; Shuman AG; Prince ME; Wolf GT; Bradford CR; McHugh JB; Brenner JC; Spector ME
Oral Oncol; 2018 Feb; 77():83-89. PubMed ID: 29362129
[TBL] [Abstract][Full Text] [Related]
39. Cell surface markers for T and B lymphocytes activation and adhesion as putative prognostic biomarkers for head and neck squamous cell carcinoma.
Andrade MC; Ferreira SB; Gonçalves LC; De-Paula AM; de Faria ES; Teixeira-Carvalho A; Martins-Filho OA
Hum Immunol; 2013 Dec; 74(12):1563-74. PubMed ID: 23994583
[TBL] [Abstract][Full Text] [Related]
40. The Prognostic Significance of the Tumor-infiltrating Programmed Cell Death-1
Shibutani M; Maeda K; Nagahara H; Fukuoka T; Nakao S; Matsutani S; Hirakawa K; Ohira M
Anticancer Res; 2017 Aug; 37(8):4165-4172. PubMed ID: 28739701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]